D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 16,840 486 World Ranking 14862 National Ranking 52

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis B and Cirrhosis are his primary areas of study. His Internal medicine research incorporates themes from HBeAg and Pathology. His study in Gastroenterology is interdisciplinary in nature, drawing from both Prospective cohort study, Liver biopsy and Hepatitis B virus.

Sang Hoon Ahn interconnects Radiology, Cancer, Carcinoma and Surgery in the investigation of issues within Hepatocellular carcinoma. Sang Hoon Ahn has researched Hepatitis B in several fields, including Liver function, Chronic hepatitis, Lamivudine, Proportional hazards model and Cohort. His studies deal with areas such as Predictive value of tests and Receiver operating characteristic as well as Cirrhosis.

His most cited work include:

  • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score (366 citations)
  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
  • Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) (260 citations)

What are the main themes of his work throughout his whole career to date?

Sang Hoon Ahn spends much of his time researching Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis B virus and Cirrhosis. In general Internal medicine study, his work on Hepatitis B, Transient elastography and Hazard ratio often relates to the realm of In patient, thereby connecting several areas of interest. His work deals with themes such as Prospective cohort study and Predictive value of tests, which intersect with Hepatitis B.

His biological study deals with issues like Lamivudine, which deal with fields such as Combination therapy. His Hepatocellular carcinoma research integrates issues from Retrospective cohort study, Carcinoma, Radiology and Oncology. His biological study spans a wide range of topics, including Liver disease, Ascites and Receiver operating characteristic.

He most often published in these fields:

  • Internal medicine (67.44%)
  • Gastroenterology (55.25%)
  • Hepatocellular carcinoma (40.12%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (67.44%)
  • Gastroenterology (55.25%)
  • Hepatocellular carcinoma (40.12%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Gastroenterology, Hepatocellular carcinoma, Cirrhosis and Hepatitis B. His Internal medicine study combines topics in areas such as Chronic hepatitis and Hepatitis B virus. His research integrates issues of Population study, HBeAg, Entecavir, Fibrosis and Cohort in his study of Gastroenterology.

The study incorporates disciplines such as Oncology, Carcinoma, Antiviral therapy and Response Evaluation Criteria in Solid Tumors in addition to Hepatocellular carcinoma. His research on Cirrhosis also deals with topics like

  • Diabetes mellitus, which have a strong connection to Fatty liver,
  • Liver disease which intersects with area such as Chronic liver disease, Disease and Hepatology. His Hepatitis B study integrates concerns from other disciplines, such as Virus, Clinical trial, Incidence and Drug.

Between 2017 and 2021, his most popular works were:

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
  • 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection (113 citations)
  • A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea (57 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Sang Hoon Ahn mainly focuses on Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis B and Cirrhosis. His work on Transient elastography as part of general Internal medicine research is often related to In patient, thus linking different fields of science. In the subject of general Gastroenterology, his work in Hepatology is often linked to Tenofovir, thereby combining diverse domains of study.

The Hepatocellular carcinoma study combines topics in areas such as Incidence, Cumulative incidence, Oncology, Carcinoma and Hazard ratio. Sang Hoon Ahn combines subjects such as Viral hepatitis, Retrospective cohort study, Univariate analysis and Population study with his study of Hepatitis B. His Cirrhosis research includes themes of Clinical trial, Diabetes mellitus, Hepatitis C, Hepatitis and Fatty liver.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Hwai I. Yang;Hwai I. Yang;Man Fung Yuen;Henry Lik Yuen Chan;Kwang Hyub Han.
Lancet Oncology (2011)

474 Citations

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee.
Journal of Hepatology (2020)

426 Citations

Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)

Kyu Sik Jung;Seung Up Kim;Sang Hoon Ahn;Young Nyun Park.
Hepatology (2011)

381 Citations

Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants

Sameer Parekh;Fabien Zoulim;Sang Hoon Ahn;Adrienne Tsai.
Journal of Virology (2003)

338 Citations

Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis

Young Eun Chon;Eun Hee Choi;Ki Jun Song;Jun Yong Park.
PLOS ONE (2012)

308 Citations

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Patrick Marcellin;Sang Hoon Ahn;Xiaoli Ma;Florin A. Caruntu.
Gastroenterology (2016)

273 Citations

A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis

Beom Kyung Kim;Kwang Hyub Han;Jun Yong Park;Sang Hoon Ahn.
The American Journal of Gastroenterology (2010)

226 Citations

Competition, Innovation and Productivity Growth: A Review of Theory and Evidence

Sanghoon Ahn.
Research Papers in Economics (2002)

218 Citations

Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.

Beom Kyung Kim;Do Young Kim;Jun Yong Park;Sang Hoon Ahn.
Liver International (2010)

210 Citations

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

Sang Hoon Ahn;Young Nyun Park;Jun Yong Park;Hye Young Chang.
Journal of Hepatology (2005)

202 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sang Hoon Ahn

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 95

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 85

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 79

Grace Lai-Hung Wong

Grace Lai-Hung Wong

Chinese University of Hong Kong

Publications: 75

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 74

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 73

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 61

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 54

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 54

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 51

Jeong Min Lee

Jeong Min Lee

Seoul National University Hospital

Publications: 47

Yasuhito Tanaka

Yasuhito Tanaka

Nagoya University

Publications: 46

Pei-Jer Chen

Pei-Jer Chen

National Taiwan University

Publications: 46

Stephen Locarnini

Stephen Locarnini

Melbourne Health

Publications: 44

Chien-Jen Chen

Chien-Jen Chen

Academia Sinica

Publications: 43

Bettina E. Hansen

Bettina E. Hansen

University Health Network

Publications: 43

Trending Scientists

Alan J. Marcus

Alan J. Marcus

Boston College

Dominic O'Brien

Dominic O'Brien

University of Oxford

John McCollum

John McCollum

Microsemi (United States)

Thomas Strohmer

Thomas Strohmer

University of California, Davis

Franck D'Agosto

Franck D'Agosto

Claude Bernard University Lyon 1

Piero Sozzani

Piero Sozzani

University of Milano-Bicocca

Frances M. Platt

Frances M. Platt

University of Oxford

Jens C. Jensenius

Jens C. Jensenius

Aarhus University

Joachim Morschhäuser

Joachim Morschhäuser

University of Würzburg

Roberto Santacroce

Roberto Santacroce

University of Pisa

Andrew J. Campbell

Andrew J. Campbell

University of Chicago

Brett A. Clementz

Brett A. Clementz

University of Georgia

Anders Ågmo

Anders Ågmo

University of Tromsø - The Arctic University of Norway

Diana B. Petitti

Diana B. Petitti

Arizona State University

Byron J. Good

Byron J. Good

Harvard University

Jonathan Hopkin

Jonathan Hopkin

London School of Economics and Political Science

Something went wrong. Please try again later.